| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 0% stake in AXSOME THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Cogent Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 9.3% stake in Inozyme Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 1.3% stake in Provention Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Annexon, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.8% stake in GH Research PLC |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 4% stake in aTyr Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in Savara Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Celcuity Inc. |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/28/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 16% stake in Tricida, Inc. |
| 07/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/23/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5% stake in Annexon, Inc. |
| 06/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/06/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/27/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.4% stake in GH Research PLC |
| 05/25/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/22/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Lyra Therapeutics, Inc. |
| 04/21/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.1% stake in Sierra Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 8% stake in VistaGen Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 6.3% stake in Tricida, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 8.2% stake in Relmada Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in aTyr Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 0.5% stake in Corvus Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Cogent Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 2.7% stake in Athira Pharma, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 7.5% stake in Aclaris Therapeutics, Inc. |
|